510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K093520Substantially Equivalent

Vivosight Topical Oct System

Michelson Diagnostics Ltd, Orpington, Kent, GB / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K093520 is the FDA 510(k) clearance record for VIVOSIGHT TOPICAL OCT SYSTEM, a class II device, cleared for Michelson Diagnostics, Ltd. on under FDA product code NQQ (System, Imaging, Optical Coherence Tomography (Oct)). FDA's definition for product code NQQ reads: "This device uses back-reflected light to create two-dimensional images versus back-reflected sound waves as are used in ultrasound imaging". FDA records list 2 510(k) clearances for Michelson Diagnostics, Ltd., from to . As of , FDA records show no recalls naming K093520.

Clearance record

Decision date
Received
(53 days to decision)
Product code
NQQ System, Imaging, Optical Coherence Tomography (Oct)
Regulation
21 CFR 892.1560
Device class
Class II
Review panel
Radiology
Applicant
Michelson Diagnostics, Ltd. 11a Grays Farm Production Vill, Orpington, Kent, GB
510(k) summary
Summary PDF
Third party review
No

Clearances, product code NQQ

Trailing 12 months
3 clearances under product code NQQ in the twelve months to October 2026, December 2025 the highest month at 2.
Show the numbers
Monthly 510(k) clearances under FDA product code NQQ, trailing twelve months
MonthClearances
November 20250
December 20252
January 20260
February 20260
March 20260
April 20261
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260